home / stock / cgen / cgen quote
Last: | $1.90 |
---|---|
Change Percent: | -1.6% |
Open: | $1.91 |
Close: | $1.90 |
High: | $1.97 |
Low: | $1.835 |
Volume: | 325,289 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.9 | $1.91 | $1.9 | $1.97 | $1.835 | 325,289 | 04-19-2024 |
$1.88 | $1.88 | $1.88 | $1.96 | $1.8301 | 308,855 | 04-18-2024 |
$1.9 | $2.03 | $1.9 | $2.04 | $1.9 | 372,625 | 04-17-2024 |
$2.03 | $1.96 | $2.03 | $2.05 | $1.9 | 451,682 | 04-16-2024 |
$1.96 | $2.11 | $1.96 | $2.19 | $1.94 | 752,822 | 04-15-2024 |
$2.13 | $2.23 | $2.13 | $2.25 | $2.09 | 388,383 | 04-12-2024 |
$2.26 | $2.26 | $2.26 | $2.27 | $2.2 | 244,801 | 04-11-2024 |
$2.26 | $2.31 | $2.26 | $2.33 | $2.23 | 279,682 | 04-10-2024 |
$2.36 | $2.34 | $2.36 | $2.4001 | $2.33 | 152,091 | 04-09-2024 |
$2.33 | $2.47 | $2.33 | $2.47 | $2.33 | 194,450 | 04-08-2024 |
$2.42 | $2.34 | $2.42 | $2.505 | $2.3114 | 366,017 | 04-05-2024 |
$2.32 | $2.38 | $2.32 | $2.47 | $2.32 | 322,750 | 04-04-2024 |
$2.43 | $2.36 | $2.43 | $2.435 | $2.34 | 145,661 | 04-03-2024 |
$2.34 | $2.43 | $2.34 | $2.43 | $2.3 | 351,047 | 04-02-2024 |
$2.47 | $2.555 | $2.47 | $2.57 | $2.45 | 241,691 | 04-01-2024 |
$2.58 | $2.54 | $2.58 | $2.625 | $2.5 | 291,035 | 03-29-2024 |
$2.58 | $2.54 | $2.58 | $2.625 | $2.5 | 291,035 | 03-28-2024 |
$2.54 | $2.49 | $2.54 | $2.58 | $2.445 | 312,741 | 03-27-2024 |
$2.5 | $2.54 | $2.5 | $2.5599 | $2.44 | 215,475 | 03-26-2024 |
$2.53 | $2.59 | $2.53 | $2.665 | $2.51 | 294,933 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Compugen Ltd. Company Name:
CGEN Stock Symbol:
NASDAQ Market:
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 PR Newswire HOLON, Israel , April 10, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pione...
Compugen to Participate in Two Upcoming Investor Conferences PR Newswire HOLON, Israel , April 3, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, tod...
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy PR Newswire HOLON, Israel , March 11, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in ...